Meals on Wheels, the Effect of a Home Food-delivery Service for Cancer Patients (RUMLE)

December 20, 2022 updated by: Christian Bitz, Copenhagen University Hospital at Herlev

Meals on Wheels, a Randomized Controlled Study on the Effect of a Home Food-delivery Service for Cancer Patients

The overall objective of the study is to investigate the effect of energy- and protein enriched home delivered meals vs. habitual diet in malnourished patients suffering from cancer on various endpoints.

Study Overview

Status

Completed

Detailed Description

Despite the fact that nutritional deterioration has been associated with patients' functional impairment, the effect of individualized nutritional support or counselling to outpatients, focussing on ordinary food, have not yet been thoroughly explored (Ravasco P. et al. 2007). A few studies have investigated the effect of nutritional counselling on quality of life (QoL) in cancer patients after discharge (Ovesen et al. 1993, Persson et al. 2002, Isenring et al. 2004, Ravasco et al. 2005a, Ravasco et al. 2005b). However, there is to our knowledge not conducted any studies examining the effect of home delivered meals on QoL and other endpoints in outpatients suffering from cancer.

The overall objective of the study is to measure the effect of energy- and protein enriched home delivered meals vs. habitual diet in malnourished outpatients diagnosed with lung cancer. The intervention diet will consist of optional protein- and energy-dense main and in-between-meals. There will be 22 different main meals and 13 in-between meals to choose between. The meals are prepared by The Nordic Kitchen of Copenhagen University Hospital Herlev. The offered main meals will consist of a selection of warm dishes taken from the ordinary menu. The in-between meals are a collection of the Delights of Herlev (dishes previously shown to increase dietary intake among in-patients). The food will be delivered to the participants' home 3 times per week, and participants can order one warm dish and ad libitum in-between meals for each day.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Herlev, Denmark, 2730
        • Herlev University Hsopital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have a nutritional risk score ≥ 3 according to NRS-2002 (Kondrup J. et al. 2003)
  • Be diagnosed with lung cancer
  • Have a life expectancy > 12 weeks
  • Not plan to loose weight or go on a diet
  • Not plan to go on vacation for > 2 weeks during the study period
  • Live at their own home
  • Live ≤ 25 km from the hospital
  • Be able to read, write and understand Danish

Exclusion Criteria:

  • Receives food from a food-delivery service
  • Have food allergies or intolerance
  • Exclusively receives enteral or parenteral nutrition
  • Suffers from cognitive impairment e.g. dementia
  • Is terminal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
The control group is not offered any home food-delivery service, but continues with their habitual diet
Experimental: Intervention group
The intervention group is offered home food-delivery service
A home food-delivery service is offered the intervention group of cancer patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life
Time Frame: 6 weeks (change from baseline)
To assess the Global QoL, a questionnaire from the European Organization for the Research and Treatment of Cancer (EORTC) QLQ-30, version 3, will be used. This is a validated, cancer-specific questionnaire with a total of 30 questions, looking back at the past week. The scoring of QoL is based on 2 specific questions with response options ranging from 1-7 which indicate very bad to very good. A Danish version of the questionnaire will be used.
6 weeks (change from baseline)
Quality of Life
Time Frame: 12 weeks (change from baseline)
To assess the Global QoL, a questionnaire from the European Organization for the Research and Treatment of Cancer (EORTC) QLQ-30, version 3, will be used. This is a validated, cancer-specific questionnaire with a total of 30 questions, looking back at the past week. The scoring of QoL is based on 2 specific questions with response options ranging from 1-7 which indicate very bad to very good. A Danish version of the questionnaire will be used.
12 weeks (change from baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand grip strength
Time Frame: 6, and 12 weeks (changes from baseline)
Hand grip strength (in kg) will be measured with a Hydraulic Hand Dynamometer. Participants will be seated with forearms rested on the arms of the chair. They are asked to perform three maximum force trials with their dominant hand and using the second handle position. The test will be repeated within 30 seconds, and the maximum grip score from the three measured values will be used.
6, and 12 weeks (changes from baseline)
30-second chair-stand test
Time Frame: 6, and 12 weeks (changes from baseline)
The 30-second-chair-stand test consist of manually counting the number of sit-stand-sit cycles completed during the 30 seconds of the test. A standard chair (with a seat height of 40cm) with or without a backrest but with armrests will be used. Initially, subject will be seated on the chair with their back in an upright position. They will be instructed to rise after the "1, 2, 3, go" command at their own preferred speed with their arms folded across their chest. If the participant is only able to perform the test by using armrest, the test will be recorded as "modified".
6, and 12 weeks (changes from baseline)
Body Weight
Time Frame: 6, and 12 weeks (changes from baseline)
Body weight will be measured to the nearest 0.1 kg following standard procedures (i.e. without shoes, minimal clothing).
6, and 12 weeks (changes from baseline)
Depression Scale
Time Frame: 6, and 12 weeks (changes from baseline)
The Center for Epidemiological Studies Depression scale (CES-D) is a short self-report scale designed to measure depressive symptoms (Hann D. et al. 1999). The questionnaire contains 20 items, divided in four domains: Somatic Retarded Activity (7 items), Depressed Affect (5 items), Positive Affect (4 items), and Interpersonal Affect (2 items), and 2 single items that complete the total score. The total score ranges from 0 to 60; a score of ≥16 indicates a depressed symptomatology. The CES-D has been validated in several samples of cancer patients, and it is often administered to inpatients with cancer (Vodermaier A. et al. 2009). A Danish version of the questionnaire will be used.
6, and 12 weeks (changes from baseline)
Total energy- and protein intake per day
Time Frame: 6, and 12 weeks (changes from baseline)
Dietary intake will be assessed by a dietary interview covering patient's dietary intake over the past week. On basis of the dietary interview the total energy and protein intake per day is estimated. A food database with energy- and protein content of various foods is used for the estimation.
6, and 12 weeks (changes from baseline)
Re-admissions with total length of stay (LOS)
Time Frame: 12 weeks, and 6 months
Data on re-admissions to the hospital and LOS will be collected from all participants medical charts (hospital medical system OPUS/GS).
12 weeks, and 6 months
Mortality
Time Frame: 12 weeks, and 6 months
Data on mortality will be collected from all participants' medical charts (hospital medical system OPUS/GS).
12 weeks, and 6 months
WHO Performance status
Time Frame: 6, and 12 weeks
6, and 12 weeks
Functional-score
Time Frame: 6 and 12 weeks
Using EORTC-QLQ-30 version 3 - looking back at the past week. Out of the 30 questions the functional score is based on 15 specific questions with 4 response options indicating either: not at all, a little, some or a lot. Involves questions related to physical-, role-, emotional-, cognitive- and social functioning.
6 and 12 weeks
Symptom-score
Time Frame: 6 and 12 weeks (changes from baseline)
Using EORTC-QLQ-30 version 3 - looking back at the past week. Out of the 30 questions the symptom score is based on 13 specific questions with 4 response options indicating either: not at all, a little, some or a lot.
6 and 12 weeks (changes from baseline)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance
Time Frame: 1, 6, and 12 weeks
All patients in the intervention group are requested to daily fulfil a compliance sheet during the whole 12-week period, where the intake of intervention dishes will be recorded. Project staff will review the completed sheets together with the study participant at mid-way (week 6) and at the final 12-week visit in order to minimize possible uncertainties. Moreover, eventual side-effects and reasons for non-compliance will be recorded.
1, 6, and 12 weeks
Evaluation
Time Frame: 12 weeks
All the intervention participants will receive an evaluation form in order to assess the acceptability of the offered meals, the food-delivery service, and a possible price they would give for this particular food-delivery service.
12 weeks
Effect of social status on total energy- and protein intake
Time Frame: Baseline
Definition of social status: if the participant is living alone or not
Baseline
Correlation between compliance (intervention group) and Quality of life
Time Frame: 12 weeks
12 weeks
Correlation between total energy- and protein intake (all participants) and Quality of life
Time Frame: 12 weeks
12 weeks
Correlation between compliance (intervention group) and Body weight
Time Frame: 12 weeks
12 weeks
Correlation between compliance (intervention group) and Hand grib strength
Time Frame: 12 weeks
12 weeks
Correlation between compliance (intervention group) and 30-second chair-stand test
Time Frame: 12 weeks
12 weeks
Correlation between compliance (intervention group) and Depression score
Time Frame: 12 weeks
12 weeks
Correlation between compliance (intervention group) and Total energy- and protein intake
Time Frame: 12 weeks
12 weeks
Correlation between compliance (intervention group) and WHO performance status
Time Frame: 12 weeks
12 weeks
Correlation between total energy- and protein intake (all participants) and Hand grip strength
Time Frame: 12 weeks
12 weeks
Correlation between total energy- and protein intake (all participants) and Body weight
Time Frame: 12 weeks
12 weeks
Correlation between total energy- and protein intake (all participants) and 30 second chair-stand test
Time Frame: 12 weeks
12 weeks
Correlation between total energy- and protein intake (all participants) and Depression scale
Time Frame: 12 weeks
12 weeks
Correlation between total energy- and protein intake (all participants) and WHO performance status
Time Frame: 12 weeks
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arne V Astrup, Professor, University of Copenhagen
  • Study Director: Eva Leedo, Cand Scient, University of Copenhagen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

February 20, 2014

First Submitted That Met QC Criteria

March 19, 2014

First Posted (Estimate)

March 21, 2014

Study Record Updates

Last Update Posted (Actual)

December 21, 2022

Last Update Submitted That Met QC Criteria

December 20, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EFFECT.A03.2014

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Clinical Trials on Home food-delivery service

Subscribe